Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Milo

Showing results (151-160 of 175) with videos related to

Pageof 18
Sort By:
Cell|November 29, 2019
Conversion of Escherichia coli to Generate All Biomass Carbon from CO<sub>2</sub>Shmuel Gleizer, Roee Ben-Nissan, Yinon M Bar-On, et al.
Plos One|July 22, 2025
Demonstration of bioplastic production from CO2 and formate using the reductive glycine pathway in E. coliDaria Fedorova, Roee Ben-Nissan, Eliya Milshtein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2023
The global human dayWilliam Fajzel, Eric D Galbraith, Christopher Barrington-Leigh, et al.
Molecular Systems Biology|October 31, 2013
Promoters maintain their relative activity levels under different growth conditionsLeeat Keren, Ora Zackay, Maya Lotan-Pompan, et al.
The EMBO Journal|May 28, 2024
A systematic exploration of bacterial form I rubisco maximal carboxylation ratesBenoit de Pins, Lior Greenspoon, Yinon M Bar-On, et al.
Frontiers in Immunology|July 30, 2019
Immunological Aspects of Approved MS TherapeuticsPaulus S Rommer, Ron Milo, May H Han, et al.
Nature Communications|March 26, 2021
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5Lihi Radomir, Matthias P Kramer, Michal Perpinial, et al.
Elife|October 21, 2020
Functional reconstitution of a bacterial CO<sub>2</sub> concentrating mechanism in <i>Escherichia coli</i>Avi I Flamholz, Eli Dugan, Cecilia Blikstad, et al.
Elife|February 21, 2024
Autotrophic growth of <i>Escherichia coli</i> is achieved by a small number of genetic changesRoee Ben Nissan, Eliya Milshtein, Vanessa Pahl, et al.
Journal of the Neurological Sciences|December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stageShay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Pageof 18

Showing results (151-160 of 175) with videos related to

Sort By:
Pageof 18
Cell|November 29, 2019
Conversion of Escherichia coli to Generate All Biomass Carbon from CO<sub>2</sub>Shmuel Gleizer, Roee Ben-Nissan, Yinon M Bar-On, et al.
Plos One|July 22, 2025
Demonstration of bioplastic production from CO2 and formate using the reductive glycine pathway in E. coliDaria Fedorova, Roee Ben-Nissan, Eliya Milshtein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2023
The global human dayWilliam Fajzel, Eric D Galbraith, Christopher Barrington-Leigh, et al.
Molecular Systems Biology|October 31, 2013
Promoters maintain their relative activity levels under different growth conditionsLeeat Keren, Ora Zackay, Maya Lotan-Pompan, et al.
The EMBO Journal|May 28, 2024
A systematic exploration of bacterial form I rubisco maximal carboxylation ratesBenoit de Pins, Lior Greenspoon, Yinon M Bar-On, et al.
Frontiers in Immunology|July 30, 2019
Immunological Aspects of Approved MS TherapeuticsPaulus S Rommer, Ron Milo, May H Han, et al.
Nature Communications|March 26, 2021
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5Lihi Radomir, Matthias P Kramer, Michal Perpinial, et al.
Elife|October 21, 2020
Functional reconstitution of a bacterial CO<sub>2</sub> concentrating mechanism in <i>Escherichia coli</i>Avi I Flamholz, Eli Dugan, Cecilia Blikstad, et al.
Elife|February 21, 2024
Autotrophic growth of <i>Escherichia coli</i> is achieved by a small number of genetic changesRoee Ben Nissan, Eliya Milshtein, Vanessa Pahl, et al.
Journal of the Neurological Sciences|December 7, 2021
Effect of natalizumab treatment on the rate of No Evidence of Disease Activity in young adults with multiple sclerosis in relation to pubertal stageShay Menascu, Aviva Fattal-Valevski, Adi Vaknin-Dembinsky, et al.
Pageof 18